Showing results (2411-2420 of 2,730) with videos related to

Sort By:
Pageof 273
Frontiers in Pharmacology|October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffoldsRobyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Journal of the American Board of Family Medicine : JABFM|December 23, 2022
How Does Prior Experience Pay Off in Large-Scale Quality Improvement Initiatives?Deborah J Cohen, Bijal A Balasubramanian, Stephan Lindner, et al.
Neoplasia (New York, N.Y.)|June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Pharmacological Research|June 24, 2022
Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramerPaulo A De Oliveira, Estefanía Moreno, Nil Casajuana-Martin, et al.
Acta Neurochirurgica. Supplement|January 1, 1996
Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidantsE D Hall, P K Andrus, S L Smith, et al.
ACS Pharmacology & Translational Science|October 21, 2022
Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput ScreenVictor Clausse, Yuhong Fang, Dingyin Tao, et al.
Journal of the American Board of Family Medicine : JABFM|September 16, 2022
How Does Prior Experience Pay Off in Large-Scale Quality Improvement Initiatives?Deborah J Cohen, Bijal A Balasubramanian, Stephan Lindner, et al.
Circulation|May 2, 2023
CIB2 Is a Novel Endogenous Repressor of Atrial RemodelingYihui Wang, Jizheng Wang, Ling Shi, et al.
Chemical Senses|March 10, 2023
No significant salt or sweet taste preference or sensitivity differences following ad libitum consumption of ultra-processed and unprocessed diets: a randomized controlled pilot studyRosario B Jaime-Lara, Alexis T Franks, Khushbu Agarwal, et al.
Toxicology and Applied Pharmacology|September 16, 2025
Systematic evaluation of Tox21 compounds that target β-adrenergic receptors and their role in cardiotoxicityXi Luo, Li Zhang, Srilatha Sakamuru, et al.
Pageof 273